These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 18259044)

  • 1. Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling.
    Zhou CC; Ahmad S; Mi T; Abbasi S; Xia L; Day MC; Ramin SM; Ahmed A; Kellems RE; Xia Y
    Hypertension; 2008 Apr; 51(4):1010-9. PubMed ID: 18259044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.
    Zhou CC; Ahmad S; Mi T; Xia L; Abbasi S; Hewett PW; Sun C; Ahmed A; Kellems RE; Xia Y
    Circ Res; 2007 Jan; 100(1):88-95. PubMed ID: 17158338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia.
    Zhou CC; Irani RA; Zhang Y; Blackwell SC; Mi T; Wen J; Shelat H; Geng YJ; Ramin SM; Kellems RE; Xia Y
    Circulation; 2010 Jan; 121(3):436-44. PubMed ID: 20065159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells.
    Xia Y; Wen H; Bobst S; Day MC; Kellems RE
    J Soc Gynecol Investig; 2003 Feb; 10(2):82-93. PubMed ID: 12593997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody-mediated complement C3a receptor activation contributes to the pathogenesis of preeclampsia.
    Wang W; Irani RA; Zhang Y; Ramin SM; Blackwell SC; Tao L; Kellems RE; Xia Y
    Hypertension; 2012 Sep; 60(3):712-21. PubMed ID: 22868393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
    Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
    Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor agonistic autoantibody-mediated soluble fms-like tyrosine kinase-1 induction contributes to impaired adrenal vasculature and decreased aldosterone production in preeclampsia.
    Siddiqui AH; Irani RA; Zhang W; Wang W; Blackwell SC; Kellems RE; Xia Y
    Hypertension; 2013 Feb; 61(2):472-9. PubMed ID: 23283357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia.
    Hubel CA; Wallukat G; Wolf M; Herse F; Rajakumar A; Roberts JM; Markovic N; Thadhani R; Luft FC; Dechend R
    Hypertension; 2007 Mar; 49(3):612-7. PubMed ID: 17210828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.
    Ye L; Gratton A; Hannan NJ; Cannon P; Deo M; Palmer KR; Tong S; Kaitu'u-Lino TJ; Brownfoot FC
    Placenta; 2016 Dec; 48():110-118. PubMed ID: 27871461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products as an upstream molecule triggers ROS-induced sFlt-1 production in extravillous trophoblasts: a novel bridge between oxidative stress and preeclampsia.
    Huang QT; Zhang M; Zhong M; Yu YH; Liang WZ; Hang LL; Gao YF; Huang LP; Wang ZJ
    Placenta; 2013 Dec; 34(12):1177-82. PubMed ID: 24144948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion.
    Hastie R; Brownfoot FC; Pritchard N; Hannan NJ; Cannon P; Nguyen V; Palmer K; Beard S; Tong S; Kaitu'u-Lino TJ
    Hypertension; 2019 Mar; 73(3):659-670. PubMed ID: 30636550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procyanidin B2 ameliorates endothelial dysfunction and impaired angiogenesis via the Nrf2/PPARĪ³/sFlt-1 axis in preeclampsia.
    Liu L; Wang R; Xu R; Chu Y; Gu W
    Pharmacol Res; 2022 Mar; 177():106127. PubMed ID: 35150862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
    Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFI16 mediates soluble Flt-1 and endoglin production by trophoblast cells.
    Li N; Fu Y; Chen W; Hu GQ; Zhou M; Yu SX; Zhang XJ; Du CT; Yang YJ
    J Hypertens; 2015 Aug; 33(8):1658-65. PubMed ID: 26002845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy.
    Parrish MR; Murphy SR; Rutland S; Wallace K; Wenzel K; Wallukat G; Keiser S; Ray LF; Dechend R; Martin JN; Granger JP; LaMarca B
    Am J Hypertens; 2010 Aug; 23(8):911-6. PubMed ID: 20431529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental trophoblast-specific overexpression of chemerin induces preeclampsia-like symptoms.
    Tan L; Chen Z; Sun F; Zhou Z; Zhang B; Wang B; Chen J; Li M; Xiao T; Neuman RI; Niu J; Verdonk K; Lu X; Zhang JV; Danser AHJ; Yang Q; Fan X
    Clin Sci (Lond); 2022 Feb; 136(4):257-272. PubMed ID: 35103285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edaravone inhibits hypoxia-induced trophoblast-soluble Fms-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia.
    Zhao Y; Zheng YF; Luo QQ; Yan T; Liu XX; Han L; Zou L
    Placenta; 2014 Jul; 35(7):476-82. PubMed ID: 24840734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.